MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. - Wikidata - wikimedia - TriplyDB

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

http://www.wikidata.org/entity/Q27851888

about

Schnitzler's syndrome: lessons from 281 cases Ibrutinib in Waldenström macroglobulinemia: latest evidence and clinical experience Role of Complement in Autoimmune Hemolytic Anemia The role of B-cell receptor inhibitors in the treatment of patients with chronic lymphocytic leukemia Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution The Yin and Yang of Toll-like receptors in cancer IRAK signalling in cancer The TLR and IL-1 signalling network at a glance Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy Emerging patterns of somatic mutations in cancer The pathogenesis of chronic lymphocytic leukemia Clinical impact of recurrently mutated genes on lymphoma diagnostics: state-of-the-art and beyond The bone marrow microenvironment in Waldenström macroglobulinemia Targeted inhibition of the deubiquitinating enzymes, USP14 and UCHL5, induces proteotoxic stress and apoptosis in Waldenström macroglobulinaemia tumour cells CIViC database The Role of Toll-Like Receptors in Hematopoietic Malignancies Recent Progress in the Molecular Recognition and Therapeutic Importance of Interleukin-1 Receptor-Associated Kinase 4 IRAK4 dimerization and trans-autophosphorylation are induced by Myddosome assembly ARID1A mutations in cancer: another epigenetic tumor suppressor?Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas.MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.Long-term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia.Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management.Prognostic factors and indications for treatment of Waldenström's Macroglobulinemia.Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management.Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.MYD88 L265P mutations are correlated with 6q deletion in Korean patients with Waldenström macroglobulinemia Concomitant lymphoplasmacytic lymphoma and plasma cell myeloma, a diagnostic challenge.Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström's Macroglobulinemia Inherited polymorphisms in hyaluronan synthase 1 predict risk of systemic B-cell malignancies but not of breast cancer The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions.c-Myc dysregulation is a co-transforming event for nuclear factor-κB activated B cells.Central nervous system involvement by Waldenström macroglobulinaemia (Bing-Neel syndrome): a multi-institutional retrospective study.Clonotypic analysis of immunoglobulin heavy chain sequences in patients with Waldenström's macroglobulinemia: correlation with MYD88 L265P somatic mutation status, clinical features, and outcome Fludarabine in Waldenstrom's macroglobulinemia.MYD88 L265P mutation contributes to the diagnosis of Bing Neel syndrome.Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.

P2860

Q21195864-81410AB9-49A9-4EA0-A55C-D9F24BDD76D5 Q26738946-C0DD9DBF-04A1-4B8E-8EAC-2AF47C4F9E6E Q26773175-AFE8CB06-69A2-4B18-B121-0594050F5356 Q26775506-D765D01F-6C0F-494F-AAF4-8B75A374638E Q26778403-19DA159B-3AB5-46E2-AA6A-6C5D968314B5 Q26784600-6ACFE366-63F3-4C5D-B7A5-BF42A9F83FB9 Q26795594-72B585A1-0F3D-41EE-81EB-95D39DDF3617 Q26823586-D6E5E87A-5019-4045-86AB-33078E93C488 Q26851526-F6B995DC-EC87-43B8-9CFF-39099BCCAC66 Q26863735-0DE7C74F-BBEA-4B03-BA2E-617BAEFFDDB2 Q27013358-712856F7-1AA3-4D8D-982D-7CD6DC9B869C Q27013581-83AE44B2-AA7F-4D79-AC32-1BA566DDBCBC Q27014126-8BAE535F-189E-4DFE-802E-7286B44B3A20 Q27025715-AD715917-DB18-459A-BCA6-F7A4762FBBED Q27027493-D5967B5D-9A22-4875-BF4D-AE9902888CCC Q27028214-D71B99DB-3D10-42A7-9100-84E74E2E6EBE Q27314737-D9B334C6-4571-4B0C-9F72-EB62BF25B973 Q27612411-50FC4EFA-5CD2-4193-8388-A6A1B229F740 Q28077740-53E61169-E16B-41E7-ABD8-8BE5B69A1A59 Q28078574-B7600143-D1E7-4089-B05B-75016DBA31A3 Q28247501-5131B29A-E70D-452E-A118-C680F59BF6E1 Q28280605-6B12C31E-5682-40AC-815E-14DECF4F804E Q30299913-0BFFF9E1-14B7-436D-9C2B-8DE33F5C10B8 Q30459093-BDA3BBF8-3EDA-48F5-A739-FCC7329EF18A Q33414529-44ABE72C-DAD9-4429-AE38-6D80E78E7D37 Q33421444-62BE0006-5210-4E38-A90C-DB37FE0935DA Q33436642-6D892473-382C-4E4B-8986-8162FEC3BF26 Q33438490-594582EB-7E19-4B13-A0D0-1C35B23A34C8 Q33617237-7BE8D476-28F4-4A29-B52A-EE702C5CB332 Q33660823-F5A816C0-9AB3-4F2A-A326-9CAA0E6B9044 Q33700063-5FB0F357-10FA-4DBB-9913-B27FEC96C3AA Q33716510-B9B0BF36-9B01-4F24-94FA-DC7465C97D9E Q33784183-D0811A9D-5CE4-467C-B742-42ADCDD3F17D Q33798887-FEC227A3-43EE-45B3-B818-15263B9DED75 Q33815997-246276FB-64D4-4394-A6D1-A86605F6D392 Q33824350-3B02D357-0226-4F0E-8F16-CEBE6574930B Q34101118-96E00CDB-30CD-4B55-BFDE-4DFF2429EABF Q34351916-289BC817-8F7D-4462-8AE2-865D70A6DA1A Q34435295-452CADB9-F4FB-47FD-B606-8F682BDEA2C3 Q34480968-EC198C10-AE11-4EB3-8CD9-6C3BF384D698

P2860

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

http://www.wikidata.org/entity/Q27851888

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@ast

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@en

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@nl

type

label

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@ast

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@en

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@nl

prefLabel

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@ast

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@en

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.

@nl

P1433

Q27851888-8D96BC2B-E175-4FFA-84C8-F4FD95E50E1F

P1476

Q27851888-28D6F936-3E94-4734-8A23-860C96EF2EBC

P2093

Q27851888-09D43271-DA1D-4E68-BC1A-31EE036C848B

Q27851888-0D2DF93E-FA90-48FD-8405-ADBE4F518409

Q27851888-14E358E8-7DA4-40F1-8B66-3AC8D92BCACB

Q27851888-4FDB9F66-53C2-47D3-BBEA-5192B5097EC3

Q27851888-6DE66CE1-AB8A-477D-B18C-07E7C0B89806

Q27851888-70360A5A-0C42-4B3E-9002-27BE3A28E8DF

Q27851888-8061CAB7-25DF-4F7D-9DA7-81661931C5F6

Q27851888-AAB644BD-2658-4CE0-96AF-B308EFD247CE

Q27851888-B39B74FA-856E-4DF1-A27A-D0D477A447BC

Q27851888-C570AA5D-4A4F-42DE-AE77-B61261B03CD3

P304

Q27851888-36A24F7F-B095-45BD-988B-6CDC7DBCC19E

P31

Q27851888-57422FA3-771B-4AD6-A9DE-D11EA91CD460

P3181

Q27851888-698DADB6-4327-4556-92C4-3398A51A1507

P356

Q27851888-EB6CA738-0D5F-439A-9E77-AFE7D746F5F3

P407

Q27851888-276012A8-03A8-4C3C-B2AC-279DC92914CE

P433

Q27851888-3B2A49F4-1BE0-4654-BF6C-CE2584BC3FB8

P478

Q27851888-2388258F-E3D5-4E94-A417-57EFAC4AE970

P50

Q27851888-1CB65B2E-DCA1-452B-B5EE-C2B03553F836

Q27851888-296C4F1B-77AD-421A-A95B-9E4C25A4A84E

P577

Q27851888-98F253B4-7CD0-4799-BA8C-BB50A824E825

P698

Q27851888-1092EB41-428C-4FA1-A9E3-F8DCAF417549

P3181

P356

P1433

The New England Journal of Medicine

P1476

MYD88 L265P somatic mutation in Waldenström's macroglobulinemia

@en

P2093

Aliyah R Sohani

http://www.w3.org/2001/XMLSchema#string

Christina Tripsas

http://www.w3.org/2001/XMLSchema#string

Christopher J Patterson

http://www.w3.org/2001/XMLSchema#string

Donald A Skifter

http://www.w3.org/2001/XMLSchema#string

Geraldine S Pinkus

http://www.w3.org/2001/XMLSchema#string

Guang Yang

http://www.w3.org/2001/XMLSchema#string

Jason M Laramie

http://www.w3.org/2001/XMLSchema#string

Lian Xu

http://www.w3.org/2001/XMLSchema#string

Nancy Lee Harris

http://www.w3.org/2001/XMLSchema#string

Patricia Sheehy

http://www.w3.org/2001/XMLSchema#string

P304

826-833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1252026

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA1200710

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

367

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22931316

http://www.w3.org/2001/XMLSchema#string